Medivir misses ME_609 end point, loses partner

AstraZeneca ( AZN) said it will discontinue its collaboration with Medivir (SSE:MVIR) to develop ME-609 antiviral cream to treat oral herpes. MVIR announced Thursday that after the compound missed its...